Clinical Trials Directory

Trials / Completed

CompletedNCT03823742

Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
163 (actual)
Sponsor
Baylor College of Medicine · Academic / Other
Sex
All
Age
7 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is find out if we can use simple tests (biomarkers) to tell us if a specific child would benefit most from CBT or from the low FODMAPs diet.

Detailed description

AIM 1: We will categorize children ages 7-12 yrs. of age with FGIDs (n=250) as to whether they have/do not have one or more of the following abnormal physiologic changes: a) Autonomic Nervous System imbalance as indicated by low heart rate variability; and/or (b) Abnormalities in gut physiology: Impaired gut barrier function (increased permeability); and/or increased abundance of species of Gammaproteobacteria and/or Clostridia; and/or Gut neuroimmune dysfunction (increased fecal chromogranin A and secretogranin 2 concentrations). AIM 2: Children will be randomized to the two treatments most commonly used in clinical practice: CBT or a low FODMAP diet for a 3-week treatment period. We will compare the response to the treatments in those with/without abnormal physiologic biomarkers at 3 weeks, 3 months, and 6 months.

Conditions

Interventions

TypeNameDescription
OTHERCognitive Behavioral TherapyCognitive Behavioral Therapy (CBT): Study treatments for the child will be conducted by a psychologist or master's level therapist. Therapists will be provided with a standardized protocol for each session . CBT treatment will be given over 1 hour, once a week, for three weeks .
OTHERLow FODMAP DietLow FODMAP Diet Condition: Subjects will receive detailed education by a dietitian about following a low FODMAP diet including a definition of FODMAPs, how to select low FODMAP foods, and how to read food labels to identify FODMAPS. The dietitian will contact the family for 1 hour, once a week, for three weeks.

Timeline

Start date
2019-02-22
Primary completion
2024-12-31
Completion
2025-12-31
First posted
2019-01-30
Last updated
2026-03-24

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03823742. Inclusion in this directory is not an endorsement.